Zobrazeno 1 - 10
of 257
pro vyhledávání: '"S, Tzartos"'
Autor:
Dimitrios Tzanetakos, Marianthi Breza, John S. Tzartos, Georgios Bontzos, Aigli G. Vakrakou, Alexandros Dermentzoglou, Ilias Gkizis, Georgios Smoustopoulos, Maria-Eleptheria Evangelopoulos, Leonidas Stefanis, Costantinos Kilidireas
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Herein, we report a case of alopecia universalis and transient accommodation spasm presented after alemtuzumab administration in a patient previously treated with fingolimod. To the best of our knowledge, this is the first report of accommodation spa
Externí odkaz:
https://doaj.org/article/833663fa08a344058271ac6cc3ff2821
Autor:
Konstantina Yiannopoulou, Aigli G. Vakrakou, Aikaterini Anastasiou, Georgia Nikolopoulou, Athina Sourdi, John S. Tzartos, Constantinos Kilidireas, Antonios Dimitrakopoulos
Publikováno v:
Diagnostics, Vol 13, Iss 12, p 2055 (2023)
Since the outbreak of coronavirus (COVID-19) in 2019, various rare movement disorders and cognitive changes have been recognized as potential neurological complications. The early treatment of some of these allows rapid recovery; therefore, we must d
Externí odkaz:
https://doaj.org/article/fc60ac7a25464c7f9769ea3de8aa09d2
Autor:
D. Tzanetakos, A. G. Vakrakou, J. S. Tzartos, G. Velonakis, M. E. Evangelopoulos, M. Anagnostouli, G. Koutsis, E. Dardiotis, E. Karavasilis, P. Toulas, L. Stefanis, C. Kilidireas
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Baló’s Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI). Existing literature lacks data especially on the therapeutic approach of the dise
Externí odkaz:
https://doaj.org/article/1bfd47c15c804e0b96f780121bccf761
Autor:
John S. Tzartos, Fotini Boufidou, Christos Stergiou, Jens Kuhle, Eline Willemse, Lina Palaiodimou, Ioanna Tsantzali, Eleni Sideri, Anastasios Bonakis, Sotirios Giannopoulos, Konstantinos I. Voumvourakis, Georgios Tsivgoulis, Socrates J. Tzartos, Elisabeth Kapaki, George P. Paraskevas
Publikováno v:
Biomolecules, Vol 12, Iss 8, p 1099 (2022)
Blood phospho-tau181 may offer a useful biomarker for Alzheimer’s disease. However, the use of either serum or plasma phospho-tau181 and their diagnostic value are currently under intense investigation. In a pilot study, we measured both serum and
Externí odkaz:
https://doaj.org/article/9e86c34c305642c1b09e892f76e67ecf
Autor:
Aigli G. Vakrakou, Dimitrios Tzanetakos, Maria-Eleptheria Evangelopoulos, Theodore Argyrakos, John S. Tzartos, Maria Anagnostouli, Elissavet Andreadou, Georgios Koutsis, Georgios Velonakis, Panagiotis Toulas, Elias Gialafos, Antonios Dimitrakopoulos, Erasmia Psimenou, Leonidas Stefanis, Constantinos Kilidireas
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Aims: Our goal was to expand the spectrum of clinico-radiologic characteristics and the possible therapeutic choices in patients with tumefactive demyelinating lesions (TDLs). Methods: A retrospective analysis of 50 patients with at least one TDL was
Externí odkaz:
https://doaj.org/article/b8d6c160c82d491e97c642659493979b
Autor:
Aigli G. Vakrakou, John S. Tzartos, Eleni Strataki, Fotini Boufidou, Eleni Dimou, Efstratios-Stylianos Pyrgelis, Vasilios C. Constantinides, George P. Paraskevas, Elisabeth Kapaki
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1262 (2022)
The aim of this study was to evaluate the association of neuronal damage biomarkers (neurofilament light chain (NFL) and total tau protein (T-tau)) in the CSF of patients with autoimmune encephalitis (AE) with the presence of an underlying malignancy
Externí odkaz:
https://doaj.org/article/88d0cbf716f440a2916801b7eda6b722
Autor:
Maria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou, Maria Veatriki Christodoulou, John S Tzartos, Dimitrios Tzanetakos, Dimitrios Kitsos, Maria Chondrogianni, Vasiliki Zouvelou, Efthimios Dardiotis, Elias Tzavellas, Ekaterini Syrigou, Vassiliki Benetou, George P Paraskevas, Sotirios Tsiodras, Georgios Tsivgoulis, Sotirios Giannopoulos
Publikováno v:
Multiple Sclerosis Journal. 29:585-594
Background Data are sparse regarding the safety of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (MS). Objective To estimate (1) the pooled proportion of MS patients experiencing relapse amo
Autor:
Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos, Georgios Koutsis, Maria-Eleptheria Evangelopoulos, Elisabeth Andreadou, Maria Anagnostouli, Marianthi Breza, John S. Tzartos, Elias Gialafos, Antonios N. Dimitrakopoulos, Georgios Velonakis, Panagiotis Toulas, Leonidas Stefanis, Constantinos Kilidireas
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists. Herein, we describe a 50-year-old woman presenting with subacute onset of left hemiparesis, memo
Externí odkaz:
https://doaj.org/article/935f0d38b7cd470d8f130926702d4eda
Autor:
Paraskevi Kazakou, Dimitrios Tzanetakos, Aigli G. Vakrakou, John S. Tzartos, Μaria-Eleptheria Evangelopoulos, Maria Anagnostouli, Panos Stathopoulos, Georgia N. Kassi, Leonidas Stefanis, Constantinos Kilidireas, Evangelia Zapanti
Publikováno v:
Clinical and Experimental Medicine.
Autoimmune thyroid disease (AITD) is the most common adverse effect in alemtuzumab (ALZ) treated relapsing–remitting (RR) multiple sclerosis (MS) patients. The objective of this prospective study was to analyze the occurrence, timing of onset, clin
Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Center Experience and a Literature Review
Autor:
Aikaterini Theodorou, Lina Palaiodimou, Apostolos Safouris, Odysseas Kargiotis, Klearchos Psychogios, Vasiliki Kotsali-Peteinelli, Aikaterini Foska, Vasiliki Zouvelou, Elias Tzavellas, Dimitrios Tzanetakos, Christina Zompola, John S. Tzartos, Konstantinos Voumvourakis, Georgios P. Paraskevas, Georgios Tsivgoulis
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 22; Pages: 6731
Background: Limited data exist regarding the prevalence of clinical, neuroimaging, and genetic markers among patients diagnosed with Cerebral Amyloid Angiopathy–related inflammation (CAA-ri). We sought to determine these characteristics in patients